What's in Palvella Therapeutics, Inc.'s pipeline?

Palvella Therapeutics, Inc. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Palvella Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: DH Bio Co., Ltd., Aevi Genomic Medicine, LLC, a Cerecor company, Aptarion Biotech AG, Amorphical Ltd., Angitia Incorporated Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/palvella-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Palvella Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Palvella Therapeutics, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
QTORIN 3.9% rapamycin anhydrous gel	QTORIN 3.9% rapamycin anhydrous gel	phase 3	immunosuppressant	mTOR	Dermatology
PTX-022	PTX-022	phase 3	PI3K inhibitor	PI3K (phosphatidylinositol 3-kinase)	Oncology

Therapeutic area mix

Dermatology · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

DH Bio Co., Ltd. · 2 shared drug classes
Aevi Genomic Medicine, LLC, a Cerecor company · 1 shared drug class
Aptarion Biotech AG · 1 shared drug class
Amorphical Ltd. · 1 shared drug class
Angitia Incorporated Limited · 1 shared drug class
Applied Biology, Inc. · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Addpharma Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Palvella Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Palvella Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/palvella-therapeutics-inc. Accessed 2026-05-16.